Inga Marie Nilsson

Overview

Best Publications

• Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B

  I. M. Nilsson;E. Berntorp;T. Löfqvist;H. Pettersson

  1205
  Citations

• Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor

  I M Nilsson;H Ljungnér;L Tengborn

  490
  Citations

• Haemophilia prophylaxis in young patients–a long‐term follow‐up

  Thomas Löfqvist;Inga Marie Nilsson;Erik Berntorp;Holger Pettersson

  441
  Citations

• A radiologic classification of hemophilic arthropathy.

  H Pettersson;A Ahlberg;I M Nilsson

  435
  Citations

• On an Inherited Autosomal Hemorrhagic Diathesis with Antihemophilic Globulin (AHG) Deficiency and Prolonged Bleeding Times1

  Inga Marie Nilsson;Margareta Blombäck;Irene Von Francken

  435
  Citations

• Intrauterine death and circulating anticoagulant ("antithromboplastin").

  Inga Marie Nilsson;Birger Åstedt;Ulla Hedner;David Berezin

  383
  Citations

• Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease.

  Lars Holmberg;Inga Marie Nilsson;Lise Borge;Margot Gunnarsson

  341
  Citations

• Induction of Immune Tolerance in Patients with Hemophilia and Antibodies to Factor VIII by Combined Treatment with Intravenous IgG, Cyclophosphamide, and Factor VIII

  Inga Marie Nilsson;Erik Berntorp;Olle Zettervall

  336
  Citations

• Determination of fibrinogen and fibrinogenolytic activity.

  Inga Marie Nilsson;Bertil Olow

  301
  Citations

• High-dose intravenous gammaglobulin: a cautionary note.

  R Ljung;Inga Marie Nilsson

  262
  Citations

• The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies

  Richard Prescott;Hiroaki Nakai;Evgueni L. Saenko;Inge Scharrer

  251
  Citations

• v. Willebrand's disease in Sweden; its pathogenesis and treatment.

  Inga Marie Nilsson;Margareta Blombäck;Birger Blombäck

  241
  Citations

• Hypergammaglobulinemia, circulating anticoagulant, and biologic false positive Wassermann reaction; a study in two cases.

  Anna-Brita Laurell;Inga Marie Nilsson

  237
  Citations

• Intranasal administration of peptides: nasal deposition, biological response, and absorption of desmopressin.

  A.S. Harris;I.M. Nilsson;Z. G-.Wagner;U. Alkner

  233
  Citations

• Molecular pathology of haemophilia B.

  P M Green;D R Bentley;R S Mibashan;I M Nilsson

  227
  Citations

• Haemophilia prophylaxis in Sweden.

  Inga Marie Nilsson;Ulla Hedner;Åke Ahlberg

  213
  Citations

• Severe Thrombotic Disease in a Young Man with Bone Marrow and Skeletal Changes and with a High Content of an Inhibitor in the Fibrinolytic System

  Inga Marie Nilsson;Hans Krook;Nils-Herman Sternby;Edvard Söderberg

  211
  Citations

• Studies on the prolonged bleeding time in von Willebrand's disease.

  P M Mannucci;F I Pareti;L Holmberg;I M Nilsson

  209
  Citations

• Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC).

  Z M Ruggeri;I M Nilsson;R Lombardi;L Holmberg

  197
  Citations

• A procedure for removing high titer antibodies by extracorporeal protein-A-sepharose adsorption in hemophilia: substitution therapy and surgery in a patient with hemophilia B and antibodies

  Inga Marie Nilsson;Svante Jonsson;Siv-Britt Sundqvist;Åke Ahlberg

  196
  Citations